Neuropharmacological profile of tetrahydrofuran in mice

Life Sciences

Volumn 80, Issue 18, 2007, Pages 1656-1663

  Werawattanachai, Nuttiya ^a   Towiwat, Pasarapa ^a   Unchern, Surachai ^a   Maher, Timothy J ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

1,4 butanediol; GABAB; Gamma butyrolactone; Gamma hydroxybutyric acid; Tetrahydrofuran

Indexed keywords

1,4 BUTANEDIOL; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 4 HYDROXYBUTYRIC ACID; BUTYLCRESOL; FLUMAZENIL; GAMMA BUTYROLACTONE; PICROTOXIN; TETRAHYDROFURAN;

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG TOLERANCE; LOCOMOTION; MALE; MENTAL TEST; MOTOR DYSFUNCTION; MOUSE; MULTIPLE CYCLE TREATMENT; NEUROPHARMACOLOGY; NONHUMAN; OPEN FIELD BEHAVIOR; RIGHTING REFLEX; ROTAROD TEST; SEDATION; STATISTICAL SIGNIFICANCE;

4-BUTYROLACTONE; ANIMALS; BEHAVIOR, ANIMAL; BUTYLENE GLYCOLS; FURANS; HYDROXYBUTYRATES; HYPNOTICS AND SEDATIVES; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; RECEPTORS, GABA; SUBSTANCE-RELATED DISORDERS;

MUS;

EID: 33947308309     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.01.050     Document Type: Article

References (33)

1. Andriamampandry C., Taleb O., Viry S., Muller C., Humbert J.P., Gobaille S., Aunis D., and Maitre M. Cloning and characterization of a rat brain receptor that binds the endogenous neuromodulator gamma-hydroxybutyrate (GHB). FASEB Journal 17 12 (2003) 1691-1693
2. Bamford D.G., Biggs D.F., Cuthbert M.F., Grant H.N., Lee G.E., Pulsford D.W., and Wragg W.R. The preparation and intravenous anaesthetic activity of tetrahydrofuran-3-ols. Journal of Pharmacy and Pharmacology 22 9 (1970) 694-699
3. B receptor-mediated increase of neurosteroids by gamma-hydroxybutyric acid. Neuropharmacology 42 6 (2002) 782-791
4. Bernhardt D., and Diekmann H. Degradation of dioxane, tetrahydrofuran and other cyclic ethers by an environmental Rhodococcus strain. Applied Microbiological Biotechnology 36 (1991) 120-123
5. Bhattacharya I., Raybon J.J., and Boje K.M. Alterations in neuronal transport but not blood-brain barrier transport are observed during gamma-hydroxybutyrate (GHB) sedative/hypnotic tolerance. Pharmaceutical Research 23 9 (2006) 2067-2077
6. Carai M.A., Quang L.S., Atzeri S., Lobina C., Maccioni P., Orru A., Gessa G.L., Maher T.J., and Colombo G. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats. Brain Research Protocols 15 2 (2005) 75-78
7. B receptor antagonist on gamma-hydroxybutyric acid mortality in mice. Annals of Emergency Medicine 45 6 (2005) 614-619
8. 1H NMR spectroscopic investigation of serum and urine in a case of acute tetrahydrofuran poisoning. Journal of Analytical Toxicology 25 4 (2001) 270-274
9. Castelli M.P., Pibiri F., Carboni G., and Piras A.P. A review of the pharmacology of NCS-382, a putative antagonist of the gamma-hydroxybutyric acid (GHB) receptor. CNS Drug Reviews 10 3 (2004) 243-260
10. Crunelli V., Emri Z., and Leresche N. Unravelling the brain targets of gamma-hydroxybutyric acid. Current Opinions in Pharmacology 6 1 (2006) 44-52
11. B receptors are involved in the behavioral effects of gamma-hydroxybutyric acid (GHB). European Journal of Pharmacology 519 3 (2005) 246-252
12. Dunham N.W., and Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. Journal of the American Pharmaceutical Association (Baltimore) 46 3 (1957) 208-209
13. El Sayed Y.M., and Sadee W. Metabolic conversion of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) to 5-fluorouracil by soluble enzymes. Cancer Research 43 (1983) 4039-4044
14. B receptors in the acute behavioral effects of GHB in baboons. Psychopharmacology 180 2 (2005) 342-351
15. Itzhak Y., and Ali S.F. Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Annals New York Academy of Science 965 (2002) 451-460
16. Kaopatumtip S. A Deadly Brew (2003). http://www.bangkokpost.net/eyetpress/a030703.html Available from: http://www.bangkokpost.net/eyetpress/a030703.html (accessed Oct 14, 2003)
17. B receptors accelerates amygdale kindling development. Cellular and Molecular Life Sciences 48 8 (1992) 748-751
18. Kerrigan S. GHB and precursors (part I): use, effects, pharmacology. Clinical and Forensic Toxicology News (2001) 1-8
19. Koek W., Chen W., Mercer S.L., Coop A., and France C.P. Discriminative stimulus effects of gamma-hydroxybutyrate: role of training dose. Journal of Pharmacology and Experimental Therapeutics 317 1 (2006) 409-417
20. Lanigan R.S., and Yamarik T.A. Final report on the safety assessment of BHT(1). International Journal of Toxicology 21 Suppl 2 (2002) 19-94
21. Li J., Stokes S.A., and Woeckener A. A tale of novel intoxication: seven cases of gamma-hydroxybutyric acid overdose. Annals Emergency Medicine 31 6 (1998) 729-736
22. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Progress in Neurobiology 51 3 (1997) 337-361
23. Malley L.A., Christoph G.R., Stadler J.C., Hansen J.F., Biesemeier J.A., and Jasti S.L. Acute and subchronic neurotoxicological evaluation of tetrahydrofuran by inhalation in rats. Drug and Chemical Toxicology 24 3 (2001) 201-219
24. Marcus R.J., Winters W.D., and Hultin E. Neuropharmacological effects induced by butanol, 4-hydroxybutyrate, 4-mercaptobutyric acid thiolactone, tetrahydrofuran, pyrrolidine, 2-deoxy-d-glucose and related substances in the rat. Neuropharmacology 15 1 (1976) 29-38
25. Moody D.E. The effect of tetrahydrofuran on biological systems: does a hepatotoxic potential exist?. Drug and Chemical Toxicology 14 4 (1991) 319-342
26. Morris J.A. Potential for gamma-butyrolactone synthesis from tetrahydrofuran and 1,4-butanediol. Microgram 33 1 (2000) 321-324
27. Quang L.S., Desai M.C., Kraner J.C., Shannon M.W., Woolf A.D., and Maher T.J. Enzyme and receptor antagonists for preventing toxicity from the gamma-hydroxybutyric acid precursor 1,4-butanediol in CD-1 mice. Annals of the New York Academy of Sciences 965 (2002) 461-472
28. Swinyard E.A., Brown W.C., and Goodman L.S. Comparative assays of antiepileptic drugs in mice and rats. Journal of Pharmacology and Experimental Therapeutics 106 3 (1952) 319-330
29. Takahara J., Yunoki S., Yakushiji W., Yamauchi J., and Yamane Y. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. Journal of Clinical Endocrinology and Metabolism 44 5 (1997) 1014-1017
30. Tallarida R.J., and Murray R.B. Manual of Pharmacologic Calculations with Computer Programs. 2nd ed. (1987), Springer, New York
31. Teter C.J., and Guthrie S.K. A comprehensive review of MDMA and GHB: two common club drugs. Pharmacotherapy 21 12 (2001) 1486-1513
32. B antagonist, CGP 35348, antagonizes the effects of baclofen, gamma-butyrolactone and HA 966 on rat striatal dopamine synthesis. Naunyn-Schmiedeberg's Archives of Pharmacology 343 2 (1991) 173-178
33. Walters J.P. ONDCP Drug Policy Information Clearinghouse Fact Sheet: Gamma Hydroxybutyrate (GHB) (2002). http://www.whitehousedrugpolicy.gov Nov:1-4, Available from: http://www.whitehousedrugpolicy.gov (accessed June 15, 2003)